Lifting weights lowers blood pressure — dose matters

Raised blood pressure affects a large share of the world's population and contributes to millions of deaths a year, which is why exercise keeps being proposed alongside or instead of medication. Aerobic training has long dominated that conversation, leaving strength training treated as an optional extra for the heart. The open question is not simply whether lifting lowers blood pressure, but what kind, how often and for how long — the variables anyone designing a programme actually has to choose. This review set out to compare training types directly and to test which programme characteristics change the size of the effect.

The authors searched PubMed and Web of Science for studies reporting the chronic effect of strength training on blood pressure, requiring programmes to last at least 4 weeks and to be published in English. Results were pooled by meta-analysis and then examined by subgroup: type of training, whether participants were combining training with medication, how long the programme ran, and how many sessions were completed each week. Systolic and diastolic blood pressure were the outcomes of interest. The review was registered prospectively on PROSPERO before the analysis was run.

All types of strength training produced a significant decrease in both systolic and diastolic blood pressure. Among people training without medication, isometric exercise lowered systolic pressure more than dynamic exercise did. The benefit was not uniform across programme design: the effect was no longer significant once a programme extended beyond 20 weeks, and it also lost significance when training frequency fell below three times per week. Weighing those subgroup patterns together, the authors concluded that moderate-intensity dynamic strength training three times a week appeared optimal for reducing blood pressure in unmedicated trainees.

This adds strength work to the body of evidence supporting exercise as a blood-pressure intervention, and lines up with a growing literature suggesting isometric protocols punch above their weight for systolic pressure specifically. It complicates the simple 'more is better' assumption by finding that longer programmes did not show larger significant effects — though whether that reflects genuine habituation, fewer and smaller long-duration trials, or dropout is not something a subgroup analysis can settle. The abstract does not report the number of included studies or participants, which limits how confidently the dose recommendation can be read. Head-to-head trials comparing isometric and dynamic protocols over matched durations remain the obvious gap.

This is a reason to treat resistance training as relevant to blood pressure and not just to muscle, with the pooled evidence pointing at consistency — around three sessions a week — as the variable that tracked with a measurable effect. The isometric finding is interesting but applies specifically to systolic pressure in people not on medication, and comes from comparisons between studies rather than within them. Nothing here speaks to replacing prescribed treatment, and blood-pressure management is something to discuss with a clinician. What it does support is that the format of a lifting programme, not merely its existence, seems to matter for this particular outcome.